SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, CTLP, BGSF on Behalf of Shareholders

NEW YORK, June 16, 2025 Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Sage Therapeutics, Inc. (NASDAQ: )'s sale to Supernus Pharmaceuticals, Inc. Under the terms of the proposed transaction, Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable upon achieving certain net sales and commercial milestones. If you are a Sage shareholder, .

Cantaloupe, Inc. (NASDAQ: )'s sale to 365 Retail Markets, LLC for $11.20 per share in cash. If you are a Cantaloupe shareholder, .  

BGSF, Inc.'s (NYSE: )'s sale of its Professional Division to INSPYR Solutions for $99 million. If you are a BGSF shareholder, .

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email  or .

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060

SOURCE Halper Sadeh LLP